Call for Support of Japanese Corporate Activities and ODA in the Global Health SectorLetter of Request Delivered to Mr. Toshimitsu Motegi, Minister of Foreign Affairs

November 21, 2025

On November 18, 2025, the Business Leaders’ Coalition for Global Health (led by Ken Shibusawa, CEO, Shibusawa and Company, Inc., hereinafter “the Coalition”), in which Eisai is a member, visited Japan’s Foreign Affairs Minister Toshimitsu Motegi and delivered him a “Request to Promote Japanese Diplomacy through Health and Medical Security”. Eisai’s CEO Haruo Naito also participated in the visit.

In August 2025, the Japanese Government revised the strategic document related to the “Co-creation for common agenda initiative” in the Development Cooperation Charter and newly designated "Health" as a strategic area. Amid significant changes in the environment surrounding international health, the Coalition requested the Ministry of Foreign Affairs to take the following four specific actions:

1. Solving global health issues directly strengthens Japan's health and medical security. While ensuring wise spending, strategically expand spending for global health within Japan’s total Official Development Assistance (ODA) budget. In addition, mobilize private investment by promoting global public-private partnerships and impact investment focused on solving challenges using ODA as a catalyst.
2. Strategically respond to funding requests from international organizations in the field of global health, while considering the opinions of Japanese companies. In particular, continue to contribute $1.08 billion in the 8th replenishment of the Global Fund, which will be holding investment strategy meetings in November 2025, and ensure Japan maintains its board seats, thereby strengthening Japan’s influence within international organizations.
3. Providing Japanese companies’ products, services, and innovations through international organizations contributes to the solution of challenges in Global South countries, and fosters the development of the Japanese economy. Establish and strengthen the Japanese Government’s mechanisms to support the promotion of procurement of Japanese companies’ products and services within international organizations in the field of global health.
4. As a country with advanced research infrastructure, excellent human resources, and pharmaceutical technology, further promote international collaboration leveraging these strengths to enhance competitiveness. In order to support the domestic development and production capacity of vaccines and medicines in Japan, which are strongly required in emergencies such as pandemics, strengthen support for research and development as well as human resource development.

Eisai’s initiatives for improving access to medicines toward the elimination of NTDs and malaria go beyond the framework of CSR activities, and instead aim to create long-term value and social impact based on our corporate concept, human health care (hhc). We aim to contribute to relieving anxiety over health and reducing health disparities of people at risk of contracting neglected tropical diseases and those suffering from diseases by strengthening our global partnerships.

About the Business Leaders’ Coalition for Global Health

The Business Leaders’ Coalition for Global Health (supporting and actively working in the fields of healthcare, especially public health and infectious disease control), led by Ken Shibusawa (CEO, Shibusawa & Company, Inc.) is a volunteer organization of Japanese Companies and others contributing to the field of global health. It is composed of executives from a wide variety of fields, including not only the healthcare sector, such as pharmaceuticals and medical devices, but also finance, trading, digital, supply chain, and more. Haruo Naito, Eisai’s CEO, is a member. 
The mission of the Business Leaders’ Coalition for Global Health is to create a future where everyone has access to the medical care they need*¹ and people around the world are healthy.
Sharing the same vision of "working together to support the healthy lives of people around the world from Japan*²,” a group of interested companies has come together to promote global health action, and set the following four missions:

1. Place global health at the heart of international cooperation

2. Clearly realize the potential of Japanese companies and take the lead

3. Build the Japan brand

4. Nurture and produce human resources who can thrive on the global stage

Official website: https://gh-leaders.jp/

*¹ This does not refer to medical care in the narrow meaning, but rather to a comprehensive health foundation that includes health and medical care. There is need for adequate access to appropriate medical care.
*² "Made With Japan" is a collaboration between governments, companies, academia, and civil society both in Japan and overseas.